Pheast Therapeutics, a pioneering force in the realm of cancer immunotherapy, is thrilled to announce the successful raising of $76 million in its latest funding round. This significant capital injection underscores robust investor confidence in the company’s innovative approach to harnessing the innate immune system through novel checkpoint therapies, designed to disrupt cancer’s defensive mechanisms. With this infusion of funds, Pheast Therapeutics will ramp up its research and development efforts, pushing forward the boundaries of immunotherapy to provide more targeted and effective treatments for cancer patients. The raised capital will enable the company to accelerate clinical trials, expand its operational capacity, and strengthen partnerships with leading academic and clinical institutions. It also provides crucial support for scaling up state-of-the-art manufacturing processes, ensuring that potential therapies can be brought to market in a timely fashion. Amid a rapidly evolving oncology landscape, this funding marks a milestone in Pheast’s mission to transform cancer care by tapping into the body’s inherent ability to fight disease naturally. As the company continues to innovate, it remains committed to offering hope to those affected by cancer and to pioneering treatments that could redefine clinical standards. The successful funding round not only validates Pheast Therapeutics’ current strategy but also fuels its ambitious future endeavors, setting the stage for groundbreaking advancements in cancer immunotherapy and ultimately aiming to change the lives of patients worldwide.
Pheast Therapeutics Secures $76M Series A to Accelerate Next-Generation Cancer Immunotherapies
Get the full Pheast Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Digital Asset
Digital Asset is a leading innovator in blockchain technology, transforming traditional and digital financial markets with privacy-enabled solutions that improve capital flow and create a more efficient, fair, and resilient global system. As the creator of the technology that launched the Canton Network, the only public layer one blockchain with privacy, and a founding member of its Global Synchronizer Foundation, Digital Asset has been a pioneer of this open, secure, and interoperable infrastructure. Founded in 2014, Digital Asset is committed to reshaping the future of finance by enabling real-time efficiencies, 24/7 global transactions, and unlocking the full potential of cryptocurrencies, digital assets, and the continued convergence of decentralized and traditional finance. In 2025, Digital Asset was included as a Unicorn in the World Economic Forum’s prestigious Innovator Communities.
$300.0M Unknown
today
White Circle
White Circle is the control layer for AI in production. We help companies test, protect, observe, and improve every AI interaction — from blocking unsafe inputs and preventing jailbreaks to analyzing user behavior and optimizing model performance.
$11.0M Seed
today
Hoplon AI
Human Convesation, Super Human Protection - Always on
$1.0M Seed
today
Isomorphic Labs
Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system. Our interdisciplinary team has developed a unified, state-of-the-art drug design engine that will transform how we design new drugs, and ultimately change the way medicine will help and heal people. Every day, and with each new breakthrough, we’re getting closer to achieving our ambitious mission to one day solve all disease
$2.1B Series b
today
Sensible Medical Innovations Ltd.
Sensible Medical has developed a non-invasive fluid status monitor (ReDS) for accurate measurement and monitoring of lung fluid for heart failure patients.
$20.0M Unknown
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Kognitiv Spark Canada | Series a | $4.7M | today |
| 2 |  Kanarys™ United States | Series a | $5.0M | today |
| 3 |  Vayu Aerospace Corp United States | Series a | $9.4M | today |
| 4 |  Hang United States | Series a | $16.0M | today |
| 5 |  Geomiq United Kingdom | Series a | $8.5M | today |